Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug 24;21(17):6091.
doi: 10.3390/ijms21176091.

Drug Resistance in Hematological Malignancies

Affiliations
Editorial

Drug Resistance in Hematological Malignancies

Patrick Auberger et al. Int J Mol Sci. .

Abstract

Hematological malignancies define a highly heterogeneous set of blood-, bone marrow-, and organ-associated diseases with highly variable prognoses that constantly relapse upon treatment [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Boulanger M., Paolillo R., Piechaczyk M., Bossis G. The SUMO Pathway in Hematomalignancies and Their Response to Therapies. Int. J. Mol. Sci. 2019;20:3895. doi: 10.3390/ijms20163895. - DOI - PMC - PubMed
    1. Cluzeau T., Furstoss N., Savy C., El Manaa W., Zerhouni M., Blot L., Calleja A., Dufies M., Dubois A., Ginet C., et al. Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Int. J. Mol. Sci. 2020;21:164. doi: 10.3390/ijms21010164. - DOI - PMC - PubMed
    1. de Jong M.R.W., Langendonk M., Reitsma B., Nijland M., van den Berg A., Ammatuna E., Visser L., van Meerten T. Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma. Int. J. Mol. Sci. 2019;20:6036. doi: 10.3390/ijms20236036. - DOI - PMC - PubMed
    1. Fernandez S., Desplat V., Villacreces A., Guitart A.V., Milpied N., Pigneux A., Vigon I., Pasquet J.-M., Dumas P.-Y. Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How? Int. J. Mol. Sci. 2019;20:3429. doi: 10.3390/ijms20143429. - DOI - PMC - PubMed
    1. Follini E., Marchesini M., Roti G. Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2019;20:3021. doi: 10.3390/ijms20123021. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources